About
Bio
Impact Factor:
4.9 (2024)
Aims of the journal:
It provides a forum for the commentary and analysis of drug discovery in the post-genomic era, with emphasis placed on the current and emerging disciplines involved and strategic planning. It is international, MEDLINE-indexed and peer-reviewed that publishes review articles covering all aspects of drug delivery research, from initial concept to potential therapeutic application and final relevance in clinical use. Each article is structured to incorporate the author’s own expert opinion on the scope for future development.
Content:
It covers chemoinformatics reviews - bioinformatics; assay development; novel screening technologies, in vitro/in vivo models, structure-based drug design, systems biology and drug case histories examining the steps involved in the preclinical and clinical development.
Readership:
Scientists and healthcare and pharmaceutical managers, academic pharmaceutical scientists and others closely involved in the delivery of drugs and other therapeutic agents.
Email
email@cision.one
Website
site@cision.one
Social media
Location
United Kingdom
Frequency
upgrade
Circulation
upgrade
Sectors
Pharmaceuticals
Bio
Impact Factor: 4.9 (2024) Aims of the journal: It provides a forum for the commentary and analysis of drug discovery in the post-genomic era, with emphasis placed on the current and emerging disciplines involved and strategic planning. It is international, MEDLINE-indexed and peer-reviewed that publishes review articles covering all aspects of drug delivery research, from initial concept to potential therapeutic application and final relevance in clinical use. Each article is structured to incorporate the author’s own expert opinion on the scope for future development. Content: It covers chemoinformatics reviews - bioinformatics; assay development; novel screening technologies, in vitro/in vivo models, structure-based drug design, systems biology and drug case histories examining the steps involved in the preclinical and clinical development. Readership: Scientists and healthcare and pharmaceutical managers, academic pharmaceutical scientists and others closely involved in the delivery of drugs and other therapeutic agents.
Website
Social media
Location
Frequency
Circulation
Sectors
Pharmaceuticals
Most recent articles by Expert Opinion on Drug Discovery
Lorem ipsum dolor sit amet, consectetur adipiscing elit
Article description
Lorem ipsum dolor sit amet, consectetur adipiscing elit
Article description
Lorem ipsum dolor sit amet, consectetur adipiscing elit
Article description
Explore outlets similar to Expert Opinion on Drug Discovery
-
SScience
Founded in 1880, with seed money from Thomas Edison, Science continues to be at the center of the very best in research across the sciences, with articles that consistently rank among the most cited in the world. Science articles are peer-reviewed, and written to appeal to both scientist and layman. Regular issue features include a news and comment section, book reviews, and coverage of scientific meetings and seminars. The News section features late-breaking news and in-depth news analysis. Compass, an opinion section, publishes letters and commentary by scientists on current science issues. The TechSight section focuses on leading edge techniques and technologies. Topics include: bioinformatics, genome sequencing, and protein sequencing. This section is published in the third issue every month. The Research section features original investigative research and reporting. Other departments include NetWatch, This Week in Science, ScienceScope, Random Samples and New Products.
ViewMMedscapeMedscape was created for medical specialists, primary care physicians, and health professionals and offers medical news, clinical trial information, review articles, journal commentary, expert columns, patient education articles and book reviews. It also includes Web-based services for verifying insurance information, Medline and other search engines, as well as a physician directory enabling users to find physicians by practice, location or specialty.
ViewTThe BMJThe BMJ is a leading international peer‑reviewed general medical journal that publishes high‑quality research, clinical reviews, expert analysis, news, opinion, education, evidence‑based guidance and commentary on clinical practice, public health, healthcare policy and related scientific and social issues affecting medicine and health professionals worldwide. It combines rigorous academic research with accessible content aimed at informing and improving healthcare decisions and outcomes globally.
ViewEEndpoints NewsEndpoints News covers Biopharmaceutical industry. Offers data-driven news and analysis for industry professionals covering research and development. Content is a combination of originally produced and curated from around the web and is available in real-time and via a daily newsletter. This site is available via RSS (Really Simple Syndication).
ViewTThe Pharmaceutical JournalThe Pharmaceutical Journal is the official professional journal of the Royal Pharmaceutical Society that provides authoritative news, analysis, and insight on pharmacy practice, pharmaceutical science, medicines use, healthcare policy, and professional developments affecting pharmacists, pharmaceutical scientists, policy makers and other healthcare professionals. Its content includes current news, expert commentary, features, opinion pieces, learning articles, and career advice, with a focus on advancing understanding of pharmacy practice and the pharmaceutical sciences globally.
ViewUse CisionOne to find more relevant outletsContact Expert Opinion on Drug Discovery and get access to over 850K accurate, up-to-date media profiles.
Discover the stories that impact your brand. In realtime.
CisionOne delivers relevant news, trends and conversations that matter to your brand with the world’s most comprehensive media monitoring service across Print, Online, TV, Radio, Social, Magazines, Podcasts and more.